Deep brain stimulation for Parkinson's disease: Australian referral guidelines.

PDF's targeted PubMed search provides you with access to journal articles from the last 90 days that may be pertinent to Parkinson's disease research. 

Not what you're looking for? Do you need informational publications about Parkinson's targeted for people living with Parkinson's, caregivers and family members?  Please browse PDF's educational materials and programs - which are all available electronically or in print.  Order for yourself, a loved one or in bulk for your patients or support group.

J Clin Neurosci 2009 Aug; 16(8):1001-8

Authors: Paul Silberstein, Richard G Bittar, Richard Boyle, Raymond Cook, Terry Coyne, Dudley O'Sullivan, Malcolm Pell, Richard Peppard, Julian Rodrigues, Peter Silburn, Rick Stell, Peter Watson,

North Shore Private Hospital, Sydney, New South Wales, Australia.

The advent of deep brain stimulation (DBS) has been an important advance in the treatment of Parkinson's disease (PD). DBS may be employed in the management of medication-refractory tremor or treatment-related motor complications, and may benefit between 4.5% and 20% of patients at some stage of their disease course. In Australia, patients with PD are reviewed by specialised DBS teams who assess the likely benefits and risks associated with DBS for each individual. The aim of these guidelines is to assist neurologists and general physicians identify patients who may benefit from referral to a DBS team. Common indications for referral are motor fluctuations and/or dyskinesias that are not adequately controlled with optimised medical therapy, medication-refractory tremor, and intolerance to medical therapy. Early referral for consideration of DBS is recommended as soon as optimised medical therapy fails to offer satisfactory motor control.

PMID: 19596113 [PubMed - as supplied by publisher]

See More

Back to PubMed Articles